Corazon (Corsee) D. Sanders, Director at Ultragenyx Pharmaceutical Inc. (RARE), sold 3,474 shares at $41.10 ($143K) on 2024-06-10, disclosed to the SEC on 2024-06-10.
Scheduled sale ($143k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.10 | 1,737 | $71K | 50.0% |
| 2 | $41.10 | 1,737 | $71K | 50.0% |
| Total | $41.10 avg | 3,474 | $143K | 100% |
| Filing → |
| ONC | SELL | 2025-12-01 | $1.8M | — | Filing → |
| ONC | SELL | 2025-09-09 | $898K | — | Filing → |
| RARE | SELL | 2025-06-23 | $180K | — | Filing → |